Navigation Links
LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Date:9/1/2009

ses," said Roger E. Morgan, M.D., Chief Medical Officer, Kowa Research Institute. "With sustained efficacy, low rates of discontinuation due to adverse events and steady, progressive increases in HDL-C observed over 52 weeks, LIVALO shows great promise for the long-term treatment of patients with hypercholesterolemia or mixed dyslipidemia."

Study 1

A total of 830 patients were randomized to one of four treatment groups: LIVALO (2 mg or 4 mg) or atorvastatin (10 mg or 20 mg), once daily. Results showed that LIVALO was comparable to atorvastatin in terms of reduction in LDL-C, and no significant differences emerged in the other endpoints. Adverse events with LIVALO and atorvastatin were also similar.

Study 2

A total of 857 patients were randomized to LIVALO (2 mg or 4 mg) or simvastatin (20 mg or 40 mg), once daily. Results showed that LIVALO 4 mg and simvastatin 40 mg were comparable in LDLC reduction, with low-dose LIVALO (2 mg) resulting in a greater reduction in LDL-C than simvastatin 20 mg. Additionally, low-dose LIVALO also showed significantly better decreases in total cholesterol and non-HDL-C than simvastatin 20 mg. Moreover, the percentage of patients who met the LDL-C goal, according to EAS guidelines, was also greater with low-dose LIVALO compared with simvastatin 20 mg. The tolerability profiles of LIVALO and simvastatin were similar.

Extension Study

The extension study demonstrated a favorable safety and tolerability profile for LIVALO 4 mg over the 52-week trial. Reductions in LDL-C were sustained over the 52-week period. In addition, a higher proportion of LIVALO-treated patients met the defined LDL-C target at the end of the extension study than at the end of the core study (74.0% NCEP and 73.5% EAS). Steady increases in HDL-C were observed throughout the extension period, reaching more than 14%
'/>"/>

SOURCE Kowa Company Ltd., Kowa Pharmaceuticals America, Inc., and Kowa Research Institute, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
2. Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability
3. Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN(R) Over Crinone(R) for Progesterone Supplementation
4. Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection
5. Survey Demonstrates Marin County Residents Support Locally Owned and Operated Marin General Hospital
6. EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip(R) Therapy
7. VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration
8. CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges
9. Study demonstrates the anti-inflammatory properties of pine bark extract
10. Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX
11. Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 “North America Cardiovascular Prosthetic ... data on the North America Cardiovascular Prosthetic Devices ... US dollars, and volume (in units) and average ... Cardiac Valve Repairs and Septal Occluders. , The ... data for each of these market categories, and ...
(Date:7/23/2014)... CHURCH, Va. -- U.S. workplaces may need to consider ... who are obese. Based on results from a new ... Environmental Hygiene ( JOEH ), workers who are ... workplace tasks, compared with their non-obese counterparts. , ... examined the endurance of 32 individuals in four categories ...
(Date:7/23/2014)... brightly hued dyes, George Mason University researchers discovered ... each other, possibly leading to new treatments for ... , George Mason researchers unraveled the mystery of ... other. "One protein interlocks with another protein like ... sends a signal down the line to the ...
(Date:7/23/2014)... Boston, MA (PRWEB) July 23, 2014 ... software technologies, the leasing and financing company LeaseQ ... in the server based software sector, they still ... sectors. , To learn more about technology ... Tirey, Founder and CEO of LeaseQ was quoted ...
(Date:7/23/2014)... Splashtop , a leader ... it has joined the RSA Ready Technology Partner ... and RSA SecurID® multi-factor authentication solution from RSA, ... , Splashtop also announced that leading Japanese Insurance ... Enterprise, the industry’s only on-premise remote access solution. ...
Breaking Medicine News(10 mins):Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Obesity linked to low endurance, increased fatigue in the workplace 2Health News:Researchers unlock the protein puzzle 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3
... A new study from Rhode Island Hospital shows that ... its emergency department are female. Injured adolescent females are more ... intimate partner, and are more likely to be injured by ... suffer an injury, however, most of the injuries are inflicted ...
... the leading provider of scientific, technical and medical information ... conference, the Current Opinion in Structural Biology & DNA ... biology of the major pathways of DNA repair and ... Topics include the involvement of DNA repair complexes in ...
... TUESDAY, May 31 (HealthDay News) -- A virus identified two years ... out not to be the culprit, new research says. ... and treat this mysterious and debilitating disease. The authors ... find that the so-called XMRV viral pathogen spotted in human samples ...
... and tonsils before the age of 20 was associated ... a large population study performed in Sweden.(1) Tonsillectomy increased ... by 33% (HR 1.33). The risk increases were just ... and appendix were both removed. However, there was no ...
... Overweight and obese people looking to drop some pounds and ... exercise, need not worry that the higher proportion of fat ... may harm their arteries, suggests a pair of new studies ... "Overweight and obese people appear to really have options ...
... and imaging capacity the number of magnetic resonance imaging ... according to a study in the June issue of the ... www.jacr.org ). Advanced medical imaging is a component ... reasons for imaging growth, including that scans have been directly ...
Cached Medicine News:Health News:Young females are victims of violent injury 2Health News:Young females are victims of violent injury 3Health News:Current opinion in structural biology and DNA repair 2Health News:Studies Refute Virus' Link to Chronic Fatigue Syndrome 2Health News:Studies Refute Virus' Link to Chronic Fatigue Syndrome 3Health News:Surgical removal of the tonsils and appendix associated with risk of early heart attack 2Health News:Surgical removal of the tonsils and appendix associated with risk of early heart attack 3Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 2Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 3Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 4
(Date:7/23/2014)... July 23, 2014 Research and ... "Prepackaged Medical Kits and Trays - Global ... http://photos.prnewswire.com/prnh/20130307/600769 ... Prepackaged Medical Kits and Trays in US$ Thousands ... Ophthalmic Custom Trays, Custom Basin Kits, Custom Ob/Gyn ...
(Date:7/23/2014)... 23, 2014 Sinovac Biotech Ltd. (NASDAQ: ... China , announced today that it has been ... ("Beijing CDC") to be a supplier of the seasonal influenza ... for 2014. The Beijing CDC plans to order ... vaccine this year from four domestic vaccine manufacturers for its ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
Breaking Medicine Technology:Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3
... DeVilbiss Healthcare has selected Business & Decision, following a ... its Microsoft Dynamics AX solution. As ... to select and implement a global solution well suited ... The primary reasons for choosing Dynamics ...
... Compliance Implementation Services (CIS), a pharmaceutical compliance consulting ... to Inc. Magazine,s fourth annual Top 5000 list ... States. (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) ... leaders of the companies on this year,s Inc. ...
Cached Medicine Technology:Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare 2Despite Economic Turmoil, CIS Named to Inc. 5000 List of Fastest-Growing Private Companies in America 2
Volume: 5 ml; Volume Graduation: 1/10 ml...
... Pipette Aid, which is for use with measuring ... comfortably with precision. It works with all types ... range from 1 mL to 100 mL.Gilsons Pipette ... replaceable membrane filters, which protect the mechanism of ...
Application: Safe and convenient filling and dispensing of glass and plastic pipets....
Trio is a portable pipette stand that keeps your Gilson pipettes within easy reach. A great accessory for use in a fume hood....
Medicine Products: